Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT03790982 · UNKNOWN
Trial details
- NCT number
- NCT03790982
- Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2020-12-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.